pI: 3.9811 |
Length (AA): 266 |
MW (Da): 29086 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 248 | 1yrb (A) | 498 | 239 | 24.00 | 0 | 0.99 | 1.23 | -1.33 |
4 | 40 | 1vma (A) | 93 | 129 | 35.00 | 1 | 0.46 | 0.473698 | 0.53 |
6 | 248 | 1yr7 (A) | 3 | 239 | 25.00 | 0 | 1 | 1.23703 | -0.39 |
7 | 54 | 3d3q (A) | 11 | 49 | 38.00 | 0 | 0.26 | 0.222951 | 1.11 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_128003)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G12790 | P-loop containing nucleoside triphosphate hydrolases superfamily protein |
Babesia bovis | BBOV_IV007690 | ATP binding protein, putative |
Brugia malayi | Bm1_56705 | protein x 0004 |
Candida albicans | CaO19.3130 | conserved hypothetical ATP-binding protein similar to S. cerevisiae YLR243W |
Candida albicans | CaO19.10642 | conserved hypothetical ATP-binding protein similar to S. cerevisiae YLR243W |
Caenorhabditis elegans | CELE_Y75B8A.14 | Protein Y75B8A.14 |
Cryptosporidium hominis | Chro.60489 | ATP binding protein |
Cryptosporidium parvum | cgd6_4270 | MinD type ATpase |
Dictyostelium discoideum | DDB_G0285197 | GPN-loop GTPase 3 |
Drosophila melanogaster | Dmel_CG2656 | CG2656 gene product from transcript CG2656-RA |
Echinococcus granulosus | EgrG_000874100 | ATP binding domain 1 family member C |
Entamoeba histolytica | EHI_042910 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_000874100 | ATP binding domain 1 family, member C |
Giardia lamblia | GL50803_8513 | ATP-binding protein |
Homo sapiens | ENSG00000111231 | GPN-loop GTPase 3 |
Leishmania braziliensis | LbrM.25.1090 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_251430.1 | hypothetical protein, conserved |
Leishmania infantum | LinJ.25.1430 | hypothetical protein, conserved |
Leishmania major | LmjF.25.1390 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.25.1390 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_09501 | GPN-loop GTPase 3 |
Mus musculus | ENSMUSG00000029464 | GPN-loop GTPase 3 |
Neospora caninum | NCLIV_069420 | hypothetical protein |
Oryza sativa | 4332772 | Os03g0337700 |
Oryza sativa | 4333905 | Os03g0714400 |
Saccharomyces cerevisiae | YLR243W | Gpn3p |
Schistosoma japonicum | Sjp_0035570 | ko:K06883 similar to ATP binding domain 1 family, member C, putative |
Schistosoma mansoni | Smp_172090 | hypothetical protein |
Schmidtea mediterranea | mk4.002684.01 | GPN-loop GTPase 3 |
Schmidtea mediterranea | mk4.004708.02 | GPN-loop GTPase 3 |
Schmidtea mediterranea | mk4.017284.01 | GPN-loop GTPase 3 |
Schmidtea mediterranea | mk4.003941.01 | GPN-loop GTPase 3 |
Trypanosoma brucei gambiense | Tbg972.3.880 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.3.1150 | Conserved hypothetical ATP binding protein, putative |
Trypanosoma congolense | TcIL3000_3_380 | Conserved hypothetical ATP binding protein, putative |
Trypanosoma cruzi | TcCLB.509455.50 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.503879.30 | hypothetical protein, conserved |
Toxoplasma gondii | TGME49_213650 | ATP-binding domain 1 family protein |
Theileria parva | TP03_0254 | ATP-binding protein, putative |
Trichomonas vaginalis | TVAG_127160 | xpa-binding protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.3.1150 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.1150 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.1150 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.3.1150 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y75B8A.14 | Caenorhabditis elegans | embryonic lethal | wormbase |
YLR243W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_213650 | Toxoplasma gondii | Probably essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.